Prevalent pregnancy, biological sex, and virologic response to antiretroviral therapy

Journal of Acquired Immune Deficiency Syndromes

Volumn 60, Issue 5, 2012, Pages 489-494

  Westreich, Daniel ^a   Evans, Denise ^b,c   Firnhaber, Cindy ^b,d   Majuba, Pappie ^d   Maskew, Mhairi ^b,c  

^a DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF THE WITWATERSRAND   (South Africa)

^c UNIVERSITY OF THE WITWATERSRAND   (South Africa)

^d RIGHT TO CARE   (South Africa)

Author keywords

highly active antiretroviral therapy; HIV; pregnancy; South Africa

Indexed keywords

EFAVIRENZ; HEMOGLOBIN; LAMIVUDINE; STAVUDINE;

ADULT; AGE; ARTICLE; BINOMIAL DISTRIBUTION; BODY MASS; BODY WEIGHT; CD4 LYMPHOCYTE COUNT; COHORT ANALYSIS; CONFIDENCE INTERVAL; EMPLOYMENT STATUS; ETHNICITY; FEMALE; FOLLOW UP; HAZARD RATIO; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; MAJOR CLINICAL STUDY; MALE; PREGNANCY; PREVALENCE; PRIORITY JOURNAL; PROPORTIONAL HAZARDS MODEL; REGRESSION ANALYSIS; SENSITIVITY ANALYSIS; SEX; SMOKING; SOUTH AFRICA; TUBERCULOSIS; VIROLOGY;

ADULT; AFRICA; ANTI-HIV AGENTS; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; COHORT STUDIES; FEMALE; HIV INFECTIONS; HUMANS; MALE; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; SOUTH AFRICA; TREATMENT OUTCOME; VIRAL LOAD;

EID: 84864284656     PISSN: 15254135     EISSN: 10779450     Source Type: Journal    
DOI: 10.1097/QAI.0b013e318256b310     Document Type: Article

References (25)

1. UNAIDS. 2009 AIDS epidemic update. Available at: http://wwwunaidsorg/en/ dataanalysis/epidemiology/2009aidsepidemicupdate/2009. Accessed July 6, 2010.
2. Black V, Hoffman RM, Sugar CA, et al. Safety and efficacy of initiating highly active antiretroviral therapy in an integrated antenatal and HIV clinic in Johannesburg, South Africa. J Acquir Immune Defic Syndr. 2008;49:276-281.
3. Sanne IM, Westreich D, Macphail AP, et al. Long term outcomes of antiretroviral therapy in a large HIV/AIDS care clinic in urban South Africa: a prospective cohort study. J Int AIDS Soc. 2009;12:38.
4. Pettifor AE, Rees HV, Kleinschmidt I, et al. Young people's sexual health in South Africa: HIV prevalence and sexual behaviors from a nationally representative household survey. AIDS. 2005;19:1525-1534. (Pubitemid 41400699)
5. UNAIDS/WHO. AIDS Epidemic Update 2007. Geneva, Switzerland: WHO; 2007.
6. Mirochnick M, Capparelli E. Pharmacokinetics of antiretrovirals in pregnant women. Clin Pharmacokinet. 2004;43:1071-1087. (Pubitemid 40013177)
7. Aweeka F, Tierney C, Stek A, et al. ACTG 5153s: pharmacokinetic exposure and virological response in HIV-1-infected pregnant women treated with PI. Presented at: 14th Conference on Retroviruses and Opportunistic Infections; February 28, 2007; Los Angeles, CA. Abstract 739S.
8. Floridia M, Giuliano M, Palmisano L, et al. Gender differences in the treatment of HIV infection. Pharmacol Res. 2008;58:173-182.
9. Roustit M, Jlaiel M, Leclercq P, et al. Pharmacokinetics and therapeutic drug monitoring of antiretrovirals in pregnant women. Br J Clin Pharmacol. 2008;66:179-195.
10. Prins M, Meyer L, Hessol NA. Sex and the course of HIV infection in the pre-and highly active antiretroviral therapy eras. AIDS. 2005;19:357-370. (Pubitemid 40446182)
11. Zhang M, Huang Q, Huang Y, et al. Beta-estradiol attenuates the anti-HIV-1 efficacy of Stavudine (D4T) in primary PBL. Retrovirology. 2008; 5:82.
12. MacCarthy S, Laher F, Nduna M, et al. Responding to her question: a review of the influence of pregnancy on HIV disease progression in the context of expanded access to HAART in Sub-Saharan Africa. AIDS Behav. 2009;(suppl 1):66-71.
13. Guay LA, Musoke P, Fleming T, et al. Intrapartum and neonatal singledose nevirapine compared with zidovudine for prevention of mother-tochild transmission of HIV-1 in Kampala, Uganda: HIVNET 012 randomised trial. Lancet. 1999;354:795-802. (Pubitemid 29415583)
14. Chi BH, Sinkala M, Stringer EM, et al. Early clinical and immune response to NNRTI-based antiretroviral therapy among women with prior exposure to single-dose nevirapine. AIDS. 2007;21:957-964. (Pubitemid 46684327)
15. Myer L, Carter RJ, Katyal M, et al. Impact of antiretroviral therapy on incidence of pregnancy among HIV-infected women in Sub-Saharan Africa: a cohort study. PLoS Med. 2010;7:e1000229.
16. French R, Brocklehurst P. The effect of pregnancy on survival in women infected with HIV: a systematic review of the literature and meta-analysis. Br J Obstet Gynaecol. 1998;105:827-835. (Pubitemid 28423497)
17. Kaplan R, Orrell C, Zwane E, et al. Loss to follow-up and mortality among pregnant women referred to a community clinic for antiretroviral treatment. AIDS. 2008;22:1679-1681.
18. Westreich D, Cole S, Nagar S, et al. Pregnancy and virologic response to antiretroviral therapy in South Africa. PLoS One. 2011; 6:e22778.
19. Fox MP, Brennan A, Maskew M, et al. Using vital registration data to update mortality among patients lost to follow-up from ART programmes: evidence from the Themba Lethu Clinic, South Africa. Trop Med Int Health. 2010;15:405-413.
20. South African National Department of Health. National antiretroviral treatment guidelines. Available at: http://www.doh.gov.za/list.php? type=HIV%20and%20AIDS. Accessed April 17, 2012.
21. Westreich D,MacPhail P, Van Rie A, et al. Effect of pulmonary tuberculosis on mortality in patients receiving HAART. AIDS. 2009;23:707-715.
22. Riddler SA, Haubrich R, DiRienzo AG, et al. Class-sparing regimens for initial treatment of HIV-1 infection. N Engl J Med. 2008;358:2095-2106. (Pubitemid 351679596)
23. Cole SR, Hernan MA. Fallibility in estimating direct effects. Int J Epidemiol. 2002;31:163-165. (Pubitemid 34284920)
24. WHO. Antiretroviral Drugs for Treating Pregnant Women and Preventing HIV Infection in Infants. Recommendations for a Public Health Approach. Geneva, Switzerland: WHO; 2010.
25. South African National Department of Health. The South African antiretroviral treatment guidelines. Available at: http://www.uj.ac.za/EN/ CorporateServices/ioha/Documentation/Documents/ART%20Guideline. pdf. Accessed April 17, 2012.